Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular basis for Epstein-Barr virus induced pathogenesis and disease.

× No keyword cloud information.

87 in total

1. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.

Authors: T Dambaugh; F Wang; K Hennessy; E Woodland; A Rickinson; E Kieff
Journal: J Virol Date: 1986-08 Impact factor: 5.103

2. Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors: L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal: Immunology Date: 1986-08 Impact factor: 7.397

3. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis.

Authors: K Falk; I Ernberg; R Sakthivel; J Davis; B Christensson; J Luka; M Okano; H L Grierson; G Klein; D T Purtilo
Journal: Int J Cancer Date: 1990-12-15 Impact factor: 7.396

4. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors: J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal: N Engl J Med Date: 1985-12-19 Impact factor: 91.245

5. Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector.

Authors: I Joab; D T Rowe; M Bodescot; J C Nicolas; P J Farrell; M Perricaudet
Journal: J Virol Date: 1987-10 Impact factor: 5.103

6. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.

Authors: R Longnecker; B Druker; T M Roberts; E Kieff
Journal: J Virol Date: 1991-07 Impact factor: 5.103

7. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

Authors: F Wang; C Gregory; C Sample; M Rowe; D Liebowitz; R Murray; A Rickinson; E Kieff
Journal: J Virol Date: 1990-05 Impact factor: 5.103

Molecular basis for Epstein-Barr virus induced pathogenesis and disease.

1. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.

2. Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

3. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis.

4. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

5. Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector.

6. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.

7. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

8. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

9. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.

10. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs).

1. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.

2. Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis.

3. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.